Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Ovarian Cancer 2016 NCI 1K22CA193860-01 PCOS, Type II diabetes and ovarian cancer risk HARRIS, HOLLY FRED HUTCHINSON CANCER RESEARCH CENTER WA $184,615
Ovarian Cancer 2016 NCI 1R35CA197605-01 Mucins and immune cell interactions in ovarian cancer pathogenesis & progression CRAMER, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,052,893
Ovarian Cancer 2016 NIAID 5R01AI033993-22 Processed Antigen Characterization by Mass Spectrometry HUNT, DONALD UNIVERSITY OF VIRGINIA VA $624,957
Ovarian Cancer 2016 NCI 5R01CA043054-29 Nuclear Function of Abl in DNA Damage Response WANG, JEAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $387,500
Ovarian Cancer 2016 NCI 5R01CA135650-07 Predictive Cancer Diagnostics and Therapy Response MOORE, ANNA MASSACHUSETTS GENERAL HOSPITAL MA $552,368
Ovarian Cancer 2016 NCI 4R01CA158415-05 Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $367,787
Ovarian Cancer 2016 NCI 4P30CA006516-51 6051 Gynecologic Cancers BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $93,366
Ovarian Cancer 2016 NCI 4P30CA006516-51 6064 Cancer Epidemiology HANKINSON, SUSAN BRIGHAM AND WOMEN'S HOSPITAL MA $82,450
Ovarian Cancer 2016 NCI 5R21CA185808-02 Genetic Testing For Men From Hereditary Cancer Families SCHWARTZ, MARC GEORGETOWN UNIVERSITY DC $169,106
Ovarian Cancer 2016 NCI 5R00CA168987-04 Discovering genomic rearrangements under selection in serious ovarian cancer SALZMAN, JULIA STANFORD UNIVERSITY CA $227,841
Ovarian Cancer 2016 NCI 5R03CA184394-02 Intraperitoneal Delivery of Targeted Nanoparticles for Metastatic Ovarian Cancer LU, XIULING UNIVERSITY OF CONNECTICUT STORRS CT $79,000
Ovarian Cancer 2016 NCI 4R01CA097061-13 Chemical genetic profiling of engineered tumor cells STOCKWELL, BRENT COLUMBIA UNIV NEW YORK MORNINGSIDE NY $350,176
Ovarian Cancer 2016 NIBIB 5R01EB019458-02 Pre-clinical quantitation of ovarian cancer tumor burden using Magnetic Particle Imaging and non-dilutive cell labeling CONOLLY, STEVEN UNIVERSITY OF CALIFORNIA BERKELEY CA $483,566
Ovarian Cancer 2016 NCI 4F32CA177094-03 Peptide-mediated delivery of siRNA for treatment of ovarian cancer KWON, ESTER MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $26,575
Ovarian Cancer 2016 NCI 5R01CA184088-02 Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy KABANOV, ALEXANDER UNIV OF NORTH CAROLINA CHAPEL HILL NC $344,549
Ovarian Cancer 2016 NIGMS 5R01GM113253-02 Role of the checkpoint clamp in double-strand break repair KAI, MIHOKO JOHNS HOPKINS UNIVERSITY MD $311,850
Ovarian Cancer 2016 NCI 5R01CA186700-02 Study of biomarkers in ovarian cancer: modulation by activity & diet intervention THOMSON, CYNTHIA UNIVERSITY OF ARIZONA AZ $615,463
Ovarian Cancer 2016 NCI 5R01CA190498-02 gp130 as a novel therapeutic target in ovarian cancer NEAMATI, NOURI UNIVERSITY OF MICHIGAN MI $376,320
Ovarian Cancer 2016 NCI 2U01CA152637-06 Breast, Colorectal, and Ovary Cancer Clinical Validation Center LI, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $1,011,430
Ovarian Cancer 2016 NCI 1U01CA200469-01 Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer ZHANG, ZHEN JOHNS HOPKINS UNIVERSITY MD $463,212
Ovarian Cancer 2016 NCI 2U01CA152990-06 Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery SKATES, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $829,757
Ovarian Cancer 2016 NCI 1U01CA200462-01 MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $951,958
Ovarian Cancer 2016 NCI 4R01CA163462-05 MUC1 Roles in ovarian cancer pathogenesis and immune therapy VLAD, ANDA MAGEE-WOMEN'S RES INST AND FOUNDATION PA $287,489
Ovarian Cancer 2016 NCI 4R01CA172743-04 Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients SUTPHEN, REBECCA UNIVERSITY OF SOUTH FLORIDA FL $657,997
Ovarian Cancer 2016 NCI 4R01CA174643-09 The role of ERRalpha/PGC-1 in disease pathogenesis MCDONNELL, DONALD DUKE UNIVERSITY NC $314,209
Ovarian Cancer 2016 NCI 4R01CA174470-25 Stimulation of Tumorigenesis by NKG2D SPIES, THOMAS FRED HUTCHINSON CANCER RESEARCH CENTER WA $581,772
Ovarian Cancer 2016 NCI 4R01CA047135-26 Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics CREWS, PHIL UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $640,899
Ovarian Cancer 2016 NCI 4UM1CA173642-04 Women's Health Initiative Cancer Survivor Cohort ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $2,396,733
Ovarian Cancer 2016 NCI 5P30CA015704-41 5446 Research Program: Women's Cancer PORTER, PEGGY FRED HUTCHINSON CANCER RESEARCH CENTER WA $69,377
Ovarian Cancer 2016 NCI 5R01CA109298-12 Ovarian Cancer: Mechanisms of Neuroendocrine Regulation SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $356,980
Ovarian Cancer 2016 NCI 1R01CA200854-01 Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women DOHERTY, JENNIFER DARTMOUTH COLLEGE NH $577,159
Ovarian Cancer 2016 NCI 4R01CA163345-05 Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics BUCKANOVICH, RONALD UNIVERSITY OF MICHIGAN MI $322,663
Ovarian Cancer 2016 NCI 1K07CA201013-01 Health Services Career Development: Improving Medical Decisions in Ovarian Cancer MEYER, LARISSA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $170,506
Ovarian Cancer 2016 NCI 1K08CA201544-01 Tumor Genetics and Response to Checkpoint Blockade in Melanoma and Ovarian Cancer SNYDER CHAREN, ALEXANDRA SLOAN-KETTERING INST CAN RESEARCH NY $180,036
Ovarian Cancer 2016 NCI 5R01CA190176-02 Effector T Cell Trafficking in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN MI $513,972
Ovarian Cancer 2016 NCI 1R03CA194643-01A1 Communicate and LEarn About youR Variant of Uncertain Significance (CLEAR VUS) SCHERR, COURTNEY NORTHWESTERN UNIVERSITY IL $87,900
Ovarian Cancer 2016 NCI 5R01CA190423-02 Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $403,926
Ovarian Cancer 2016 NCI 4R01CA168758-04 Epidemiologic factors and survival by molecular subtypes of ovarian cancer ROSSING, MARY FRED HUTCHINSON CANCER RESEARCH CENTER WA $654,304
Ovarian Cancer 2016 NCI 1R03CA191527-01A1 Deletion of Arid1a and Kras as a Model of Endometriosis-Associated Ovarian Cancer HAWKINS, SHANNON INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $78,000
Ovarian Cancer 2016 NCI 1R21CA194965-01A1 Evolving Model of Cancer Susceptibility Testing: Clinical Decisions & Outcomes SCHWARTZ, MARC GEORGETOWN UNIVERSITY DC $202,928
Ovarian Cancer 2016 NIGMS 5R01GM113940-02 NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers YOU, YOUNGJAE UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $108,595
Ovarian Cancer 2016 NCI 4R01CA169604-04 Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tiss LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $327,850
Ovarian Cancer 2016 NCI 1R21CA181994-01A1 Targeted Molecular Imaging of Cell Death in Ovarian Cancer MILLWARD, STEVEN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $174,000
Ovarian Cancer 2016 NCI 4R01CA169200-04 The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $372,052
Ovarian Cancer 2016 NCI 5R01CA181543-03 Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells BRUGGE, JOAN HARVARD MEDICAL SCHOOL MA $396,541
Ovarian Cancer 2016 NCI 5R01CA183040-03 Ovarian cancer gene therapy using HPV pseudovirion WU, TZYY-CHOOU JOHNS HOPKINS UNIVERSITY MD $336,150
Ovarian Cancer 2016 NCI 2R01CA136512-06A1 BRCA1 Function in Post-Damage Nuclear Foci LIVINGSTON, DAVID DANA-FARBER CANCER INST MA $515,452
Ovarian Cancer 2016 NCI 2R01CA119171-09A1 Nutrition and Physical Activity Assessment Study (NPAAS) NEUHOUSER, MARIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $843,797
Ovarian Cancer 2016 NCI 1R01CA193249-01A1 Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance LUTGENDORF, SUSAN UNIVERSITY OF IOWA IA $668,888
Ovarian Cancer 2016 NCI 5R01CA115483-12 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA AT DAVIS CA $337,307
Ovarian Cancer 2016 NCI 5R01CA142698-07 Molecular mechanism and relevance of microRNAs in DSB repair pathway choice CHOWDHURY, DIPANJAN DANA-FARBER CANCER INST MA $409,002
Ovarian Cancer 2016 NCI 1R01CA193511-01A1 NOX4 mediates oxidative stress in ovarian tumor growth and treatment response JIANG, BINGHUA THOMAS JEFFERSON UNIVERSITY PA $356,850
Ovarian Cancer 2016 NCI 1R01CA194064-01A1 Combination Therapy of OvCa with Oligonucleotides and Photodynamic Therapy MING, XIN UNIV OF NORTH CAROLINA CHAPEL HILL NC $84,166
Ovarian Cancer 2016 NICHD 1R01HD083930-01A1 Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation ZELINSKI, MARY OREGON HEALTH & SCIENCE UNIVERSITY OR $605,663
Ovarian Cancer 2016 NCI 2R01CA136494-07A1 Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle MUKHERJEE, PRIYABRATA UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $116,351
Ovarian Cancer 2016 NCI 1R01CA202846-01 Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles YANG, LILY EMORY UNIVERSITY GA $425,268
Ovarian Cancer 2016 NCI 5P30CA010815-47 6194 Tumor Microenvironment and Metastasis ALTIERI, DARIO WISTAR INSTITUTE PA $31,844
Ovarian Cancer 2016 NCI 1R01CA202919-01 Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer ZHANG, RUGANG WISTAR INSTITUTE PA $434,625
Ovarian Cancer 2016 NCI 1R01CA194498-01A1 CDK12 in Ovarian Cancer KARNITZ, LARRY MAYO CLINIC ROCHESTER MN $383,982
Ovarian Cancer 2016 NCI 5R21CA191690-02 Identifying BRCA1 protein variants that provide resistance to therapy JOHNSON, NEIL RESEARCH INST OF FOX CHASE CAN CTR PA $232,943
Ovarian Cancer 2016 NCI 1R21CA191243-01A1 Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid SULCHEK, TODD GEORGIA INSTITUTE OF TECHNOLOGY GA $222,446
Ovarian Cancer 2016 NCI 5U10CA180860-03 Integrated Translational Genoproteomics Center at Washington University MUTCH, DAVID WASHINGTON UNIVERSITY MO $428,007
Ovarian Cancer 2016 NIGMS 5R01GM111093-03 Glycosylation-dependent mechanisms regulating ovarian tumor cell survival BELLIS, SUSAN UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $279,300
Ovarian Cancer 2016 NLM 5K01LM012100-02 Informatic Methods for Differential Signaling and Immune Co-Regulatory Expression ENG, KEVIN ROSWELL PARK CANCER INSTITUTE CORP NY $166,879
Ovarian Cancer 2016 NCI 5R01CA175318-02 A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer HATEFI, ARASH RUTGERS, THE STATE UNIV OF N.J. NJ $354,563
Ovarian Cancer 2016 NCI 5R01CA095175-12 Analysis of BRCA1 Recombination Functions SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER MA $328,700
Ovarian Cancer 2016 NCI 4R01CA172272-04 The BARD1 tumor suppressor and breast cancer BAER, RICHARD COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Ovarian Cancer 2016 NCI 5K99CA194309-02 Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer AIRD, KATHERINE WISTAR INSTITUTE PA $115,014
Ovarian Cancer 2016 NCI 1F31CA203039-01 Design and synthesis of stabilized pironetin analogs for the treatment of resistant ovarian cancers COULUP, SARA UNIVERSITY OF MINNESOTA MN $29,327
Ovarian Cancer 2016 NCI 1R44CA203350-01 Genetic Cytology for Ovarian and Endometrial Cancer Screening KINDE, ISAAC PAPGENE, INC. MD $296,784
Ovarian Cancer 2016 NCI 5R03CA184306-02 Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors LUTGENDORF, SUSAN UNIVERSITY OF IOWA IA $79,565
Ovarian Cancer 2016 NCI 1R01CA196631-01A1 A network platform to connect drug response and prognosis phenotypes for cancers LI, HU MAYO CLINIC ROCHESTER MN $395,911
Ovarian Cancer 2016 NCI 1F31CA203476-01 A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines RADFORD, DAVID UNIVERSITY OF UTAH UT $34,274
Ovarian Cancer 2016 NCI 1R01CA203348-01 Blocking NK cell shedding of CD16a to increase cancer cell killing WALCHECK, BRUCE UNIVERSITY OF MINNESOTA MN $443,533
Ovarian Cancer 2016 NCI 5R01CA138835-07 The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair GREENBERG, ROGER UNIVERSITY OF PENNSYLVANIA PA $317,509
Ovarian Cancer 2016 NCI 4R01CA160669-05 Mitochondrial DNA and Ovarian Cancer Risk and Survival COOK, LINDA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $318,673
Ovarian Cancer 2016 NCI 4R01CA163377-05 Role of EZH2 in Epithelial Ovarian Cancer ZHANG, RUGANG WISTAR INSTITUTE PA $354,825
Ovarian Cancer 2016 NCI 5R01CA184502-03 (PQD5) Avatar-directed Treatment for Ovarian Cancer WEROHA, SARAVUT MAYO CLINIC ROCHESTER MN $714,297
Ovarian Cancer 2016 NIGMS 5SC1CA199810-02 Novel Nanotechnology Platform for Breast Cancer Treatment AKALA, EMMANUEL HOWARD UNIVERSITY DC $377,500
Ovarian Cancer 2016 NCI 4R01CA180769-08 Signaling Connections Controlling Cell Motility and Invasion SCHLAEPFER, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $376,500
Ovarian Cancer 2016 NCI 4U01CA168409-05 COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS POWERS, SCOTT COLD SPRING HARBOR LABORATORY NY $1,420,487
Ovarian Cancer 2016 NCI 4U01CA176058-04 The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center HAHN, WILLIAM DANA-FARBER CANCER INST MA $698,459
Ovarian Cancer 2016 NCI 5R01CA184968-03 (PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers SIKIC, BRANIMIR STANFORD UNIVERSITY CA $509,161
Ovarian Cancer 2016 NCI 5R21CA194626-02 (PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women ORSULIC, SANDRA CEDARS-SINAI MEDICAL CENTER CA $190,313
Ovarian Cancer 2016 NCI 5R01CA176166-03 Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer CANTOR, SHARON UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $347,563
Ovarian Cancer 2016 NCI 4R01CA131407-09 Re-activating Memory T Cells in the Microenvironment of Human Tumors BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $326,400
Ovarian Cancer 2016 NCI 7R01CA157481-05 Bmi-1, a potential therapeutic target in ovarian cancer BHATTACHARYA, RESHAM UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $311,480
Ovarian Cancer 2016 NICHD 4R01HD073499-04 Genetic regulation of ovariole development in Drosophila EXTAVOUR, CASSANDRA HARVARD UNIVERSITY MA $413,174
Ovarian Cancer 2016 NCI 4R01CA174904-04 Roles of Chromatin Modification in BRCA1 Dependent DNA Repair GREENBERG, ROGER UNIVERSITY OF PENNSYLVANIA PA $332,000
Ovarian Cancer 2016 NCI 5R21CA198409-02 Targeting Ovarian Cancer Stem Cells Through Selective Inhibition of ALDH1A1 HURLEY, THOMAS INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $169,467
Ovarian Cancer 2016 NCI 5R01CA181258-03 Chemically Programmed Bispecific Antibodies for Cancer Therapy RADER, CHRISTOPH SCRIPPS FLORIDA FL $398,400
Ovarian Cancer 2016 NCI 5R01CA182413-02 Origins of Ovarian Carcinoma NIKITIN, ALEXANDER CORNELL UNIVERSITY NY $358,780
Ovarian Cancer 2016 NCI 5R01CA188900-02 Novel immunological biomarkers ovarian cancer prognosis SEGAL, BRAHM ROSWELL PARK CANCER INSTITUTE CORP NY $646,389
Ovarian Cancer 2016 NCI 4U01CA176270-04 Profiling cancer neoantigen repertoires and validating immunotherapy targets MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $1,064,486
Ovarian Cancer 2016 NCI 5R01CA195670-02 The Tumor Suppressor Role of SMARCA4 in SCCOHT WEISSMAN, BERNARD UNIV OF NORTH CAROLINA CHAPEL HILL NC $781,296
Ovarian Cancer 2016 NCI 5R01CA197359-02 Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy BERLIN, JACOB BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $388,875
Ovarian Cancer 2016 NCI 4R01CA175480-04 Tumor-targeted Polymersomes to image and Treat Ovarian Cancer CHENG, ZHILIANG UNIVERSITY OF PENNSYLVANIA PA $327,652
Ovarian Cancer 2016 NCI 5R01CA176078-03 Dissecting the role of STAT3 and targeting ovarian cancer KARUPPAIYAH, SELVENDIRAN OHIO STATE UNIVERSITY OH $320,524
Ovarian Cancer 2016 NIGMS 1R35GM118175-01 Homologous recombination mechanisms in mammalian cells JASIN, MARIA SLOAN-KETTERING INST CAN RESEARCH NY $293,822
Ovarian Cancer 2016 NCI 1R01CA203971-01 Deubiquitinases in regulation of BRCA1 pathway YUAN, JIAN MAYO CLINIC ROCHESTER MN $363,713
Ovarian Cancer 2016 NCI 4P01CA066726-19 5805 Clinical Trials in Mesothelioma STERMAN, DANIEL UNIVERSITY OF PENNSYLVANIA PA $302,808
Ovarian Cancer 2016 NCI 5R01CA132755-09 Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis YU, XIAOCHUN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $382,500
Ovarian Cancer 2016 NCI 4R01CA177909-04 Platelets promote growth of ovarian cancer AFSHAR-KHARGHAN, VAHID UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Ovarian Cancer 2016 NCI 1R01CA204119-01 Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI GENKINGER, JEANINE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $401,317
Ovarian Cancer 2016 NCI 5F32CA196008-02 Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer CHEN, HSING-YU HARVARD MEDICAL SCHOOL MA $58,002
Ovarian Cancer 2016 NCI 4R01CA178687-04 Effects of common polymorphisms in immune sensors in tumor immunosurveillance CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $387,166
Ovarian Cancer 2016 NIBIB 4R01EB016582-04 Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer NOLTE, DAVID PURDUE UNIVERSITY IN $330,976
Ovarian Cancer 2016 NCI 7R01CA172404-04 Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer RAMUS, SUSAN UNIVERSITY OF NEW SOUTH WALES AUSTRA $491,893
Ovarian Cancer 2016 NCI 4P30CA046592-28 6455 Cancer Genetics WICHA, MAX UNIVERSITY OF MICHIGAN MI $241,479
Ovarian Cancer 2016 NCI 4R01CA121113-10 Large-scale Genetic Analyses of Human Cancer VELCULESCU, VICTOR JOHNS HOPKINS UNIVERSITY MD $279,212
Ovarian Cancer 2016 NCI 5R01CA188251-03 Molecular Insights into the Fanconi Anemia Tumor Suppressor Signaling Pathway FEI, PEIWEN UNIVERSITY OF HAWAII AT MANOA HI $319,550
Ovarian Cancer 2016 NCI 5U01CA181628-03 Novel Activatable Fluorophores for Multicolor Fluorescence-Guided Cancer Surgery PTASZEK, MARCIN UNIVERSITY OF MARYLAND BALT CO CAMPUS MD $196,403
Ovarian Cancer 2016 NCI 1R03CA191543-01A1 Enhancing at-Risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer HURTADO DE MENDOZA CASAUS, ALEJANDRA GEORGETOWN UNIVERSITY DC $79,305
Ovarian Cancer 2016 NCI 4R01CA164122-05 B7-H1 Signaling in Ovarian Cancer CURIEL, TYLER UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $310,213
Ovarian Cancer 2016 NCI 4R01CA164729-05 Integrative Cancer Genomics: Drivers, Pathways and Drugs PE'ER, DANA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $464,984
Ovarian Cancer 2016 NCI 7R01CA196200-02 Ovarian Cancer Chemoprevention BENBROOK, DORIS UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $503,992
Ovarian Cancer 2016 NCI 5R01CA131582-07 Identification of Ovarian Cancer Plasma Biomarkers SPEICHER, DAVID WISTAR INSTITUTE PA $452,569
Ovarian Cancer 2016 NCI 5R01CA188571-02 DYRK1A signaling in control of cell growth, proliferation and DNA damage repair LITOVCHICK, LARISA VIRGINIA COMMONWEALTH UNIVERSITY VA $341,494
Ovarian Cancer 2016 NCI 4R01CA166907-04 Transplatin: A Novel Agent to Mitigate Cisplatin Toxicity RAMKUMAR, VICKRAM SOUTHERN ILLINOIS UNIVERSITY SCH OF MED IL $302,080
Ovarian Cancer 2016 NCI 4R01CA124515-11 Vascular Leukocytes Influence the Tumor Microenvironment CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $350,170
Ovarian Cancer 2016 NIGMS 1R15GM119116-01 New Photostable Nanoprobes for Real-time Imaging of Single Live Cells XU, X. NANCY OLD DOMINION UNIVERSITY VA $465,000
Ovarian Cancer 2016 NCI 1R21CA205322-01 Multiplexed exosome analyses with DNA barcoding LEE, HAKHO MASSACHUSETTS GENERAL HOSPITAL MA $239,828
Ovarian Cancer 2016 NCI 1R21CA198263-01A1 Cbx-3/HP-1gamma deficiency confers anti-tumor immunity THAI, TO-HA BETH ISRAEL DEACONESS MEDICAL CENTER MA $188,138
Ovarian Cancer 2016 NCI 1R21CA205819-01 Modeling the impact of mutations in ubiquitin ligase genes on transcriptional programs in endometrial cancer LESLIE, CHRISTINA SLOAN-KETTERING INST CAN RESEARCH NY $223,677
Ovarian Cancer 2016 NCI 4U01CA168870-05 Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer ABBOTT, KAREN UNIV OF ARKANSAS FOR MED SCIS AR $360,837
Ovarian Cancer 2016 NCI 1R01CA196619-01A1 Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm CHO, KATHLEEN UNIVERSITY OF MICHIGAN MI $471,755
Ovarian Cancer 2016 NCCIH 1R01AT008824-01A1 Botanical derived progestins and their impact on women's health BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $359,775
Ovarian Cancer 2016 NIMHD 1R01MD009697-01A1 Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival BRISTOW, ROBERT UNIVERSITY OF CALIFORNIA-IRVINE CA $386,250
Ovarian Cancer 2016 NCI 5R01CA199004-02 Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer MOR, GIL YALE UNIVERSITY CT $511,177
Ovarian Cancer 2016 NCI 1R01CA197780-01A1 Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer DIFEO, ANALISA CASE WESTERN RESERVE UNIVERSITY OH $376,963
Ovarian Cancer 2016 NCI 1R01CA193965-01A1 Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening TERRY, KATHRYN BRIGHAM AND WOMEN'S HOSPITAL MA $438,367
Ovarian Cancer 2016 NCI 1R01CA197784-01A1 Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients PASICK, RENA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $652,127
Ovarian Cancer 2016 NCI 1R01CA200231-01A1 PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM ELLENBERGER, TOM WASHINGTON UNIVERSITY MO $38,898
Ovarian Cancer 2016 NCI 1R01CA197976-01A1 The Hippo/YAP Signaling Pathway in Ovarian High Grade Serous Carcinoma WANG, CHENG UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $344,269
Ovarian Cancer 2016 NCI 5R21CA191725-02 4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci FREEDMAN, MATTHEW DANA-FARBER CANCER INST MA $185,077
Ovarian Cancer 2016 NCI 5R21CA187289-02 Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer LIM, CAROL UNIVERSITY OF UTAH UT $194,445
Ovarian Cancer 2016 NCI 5R01CA193578-02 Tunable Microchip Sorting of BRCA1 Nuclear Assemblies KELLY, DEBORAH VIRGINIA POLYTECHNIC INST AND ST UNIV VA $358,743
Ovarian Cancer 2016 NCI 5F30CA192648-02 Deciphering Links Between Inflammation and Cancer with IMP-1 Inhibitors MAHAPATRA, LILY UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $48,576
Ovarian Cancer 2016 NCI 1K99CA197487-01A1 Role of DEAD-box helicase in microRNA biogenesis and Cancer HAN, CECIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $101,631
Ovarian Cancer 2016 NCI 5R21CA198795-02 PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer AVRIL, NORBERT CASE WESTERN RESERVE UNIVERSITY OH $222,296
Ovarian Cancer 2016 NCI 5R01CA193136-02 MDSCs in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN MI $498,257
Ovarian Cancer 2016 NINR 5F31NR015170-02 Hormone Therapy Decision Making in Older Women HUNTER, MARY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $35,027
Ovarian Cancer 2016 NCI 5R01CA102310-13 Role of FAK in Tumorigenesis SCHLAEPFER, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $331,313
Ovarian Cancer 2016 NCI 5R01CA135354-06 ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $380,000
Ovarian Cancer 2016 NCI 5F30CA183395-03 Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy COCCE, KIMBERLY DUKE UNIVERSITY NC $33,987
Ovarian Cancer 2016 NIAID 4K06AI004739-55 BIOCHEMISTRY OF VIRAL REPLICATION GREEN, MAURICE SAINT LOUIS UNIVERSITY MO $33,939
Ovarian Cancer 2016 NCI 4R01CA111882-10 Regulation of Adhesion and Proteolysis in Ovarian Cancer LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $272,318
Ovarian Cancer 2016 NCI 4P50CA159981-04 5590 Inhibition of indole-amine 2,3 dioxygenase to Enhance Ovarian Tumor Immunity ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $109,724
Ovarian Cancer 2016 NCI 4P50CA159981-04 5591 Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov SHRIKANT, PROTUL ROSWELL PARK CANCER INSTITUTE CORP NY $144,478
Ovarian Cancer 2016 NCI 4P50CA159981-04 5593 MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1 KALINSKI, PAWEL UNIVERSITY OF PITTSBURGH PA $149,868
Ovarian Cancer 2016 NCI 4P50CA159981-04 5595 Administrative Core ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $1,278
Ovarian Cancer 2016 NCI 4P50CA159981-04 5596 Biospecimen Core MORRISON, CARL ROSWELL PARK CANCER INSTITUTE CORP NY $1,282
Ovarian Cancer 2016 NCI 4P50CA159981-04 5597 Biostatistics/Medical Informatics HUTSON, ALAN ROSWELL PARK CANCER INSTITUTE CORP NY $1,402
Ovarian Cancer 2016 NCI 4P50CA159981-04 5598 Immune Monitoring Core WALLACE, PAUL ROSWELL PARK CANCER INSTITUTE CORP NY $1,068
Ovarian Cancer 2016 NCI 4P50CA159981-04 5599 Developmental Research Program MOYSICH, KIRSTEN ROSWELL PARK CANCER INSTITUTE CORP NY $1,320
Ovarian Cancer 2016 NCI 4P50CA159981-04 5600 Career Development Program LELE, SHASHIKANT ROSWELL PARK CANCER INSTITUTE CORP NY $1,373
Ovarian Cancer 2016 NCI 5R21CA186846-03 Integrated Microfluidic Exosome Profiling for Early Detection of Cancer ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE KS $212,274
Ovarian Cancer 2016 NCI 5R01CA190237-02 Targeting BRCA Deficient Cells for Killing POMERANTZ, RICHARD TEMPLE UNIV OF THE COMMONWEALTH PA $356,850
Ovarian Cancer 2016 NCI 5P30CA047904-28 6388 Cancer Epidemiology and Prevention Program (Project-005) YUAN, JIAN-MIN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $35,976
Ovarian Cancer 2016 NCI 5P30CA047904-28 6390 Breast and Ovarian Cancer Program (Project-007) LEE, ADRIAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $34,673
Ovarian Cancer 2016 NCI 1R01CA206561-01 Quantitative assessment of the role of collagen alterations in ovarian cancer CAMPAGNOLA, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $387,549
Ovarian Cancer 2016 NCI 5F31CA186376-02 Role of estrogen receptor-alpha in ovarian cancer ANDERSEN, COURTNEY UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $8,586
Ovarian Cancer 2016 NCI 5R21CA197225-02 Generation and characterization of adduct-specific anti cisplatin DNA antibodies SCHARER, ORLANDO STATE UNIVERSITY NEW YORK STONY BROOK NY $170,210
Ovarian Cancer 2016 NCI 5R01CA188943-02 Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors HILDEBRANDT, MICHELLE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $1,200,669
Ovarian Cancer 2016 NCI 4R01CA180710-04 Targeting nucleotide excision repair in combination cancer therapy TURCHI, JOHN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $323,700
Ovarian Cancer 2016 NCI 5R01CA188025-03 Iron addiction and the biology of ovarian cancer TORTI, SUZY UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $386,630
Ovarian Cancer 2016 NCI 4U01CA116167-09 BRCA1 and BRCA2 missense mutations and breast cancer risk COUCH, FERGUS MAYO CLINIC ROCHESTER MN $527,128
Ovarian Cancer 2016 NCI 4K07CA166210-04 Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer WRIGHT, ALEXI DANA-FARBER CANCER INST MA $177,120
Ovarian Cancer 2016 NCI 5R00CA184043-04 Targeting Ovarian Cancer via Cooperative Oncogene Interactions HARGREAVES, DIANA SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $249,000
Ovarian Cancer 2016 NCI 5R01CA181808-03 Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis RICHARDS, JOANNE BAYLOR COLLEGE OF MEDICINE TX $356,313
Ovarian Cancer 2016 NCI 5R35CA197458-02 GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER KING, MARY-CLAIRE UNIVERSITY OF WASHINGTON WA $899,750
Ovarian Cancer 2016 NCI 4K01CA172591-05 EGF receptor, DNA methylation and platinum resistance in ovarian cancer SAMUDIO-RUIZ, SABRINA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $129,216
Ovarian Cancer 2016 NCI 5UM1CA182910-04 Shanghai Womens Health Study ZHENG, WEI VANDERBILT UNIVERSITY MEDICAL CENTER TN $624,799
Ovarian Cancer 2016 RMAP 5UH3TR000943-04 Novel extra cellular RNA-based combinatorial RNA inhibition therapy SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $1,000,000
Ovarian Cancer 2016 NCI 4F31CA174316-05 Structural mutation analysis of PTEN and its possible genotype-phenotype correlat SMITH, IRIS UNIVERSITY OF HOUSTON TX $29,078
Ovarian Cancer 2016 NCI 4U54CA163071-05 7991 Identifying Cancer Health Communication Channels for Hispanic Audiences JIMENEZ, JUILO PONCE SCHOOL OF MEDICINE PR $88,410
Ovarian Cancer 2016 NCI 5R01CA187209-03 Functional analysis of BRCA1 in DNA damage response and tumor suppression YU, XIAOCHUN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $352,750
Ovarian Cancer 2016 NCI 5R21CA190930-02 Subharmonic Contrast Ultrasound for Improved Characterization of Adnexal Masses FORSBERG, FLEMMING THOMAS JEFFERSON UNIVERSITY PA $169,650
Ovarian Cancer 2016 NCI 5F31CA192891-03 Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer PRICE, JESSICA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $44,343
Ovarian Cancer 2016 NCI 5K99CA194318-02 Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer BITLER, BENJAMIN WISTAR INSTITUTE PA $115,014
Ovarian Cancer 2016 NCI 5R03CA198822-02 Scutellaria Baicalensis Targets HIF-1(alpha) in Cancer SYED, VIQAR HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $77,878
Ovarian Cancer 2016 NCI 5F31CA186625-03 Refining ovarian cancer subtype classifiers to incorporate biologic features RUDD, JAMES DARTMOUTH COLLEGE NH $43,576
Ovarian Cancer 2016 NCI 5R01CA195723-02 Validating a mouse model of ovarian cancer for early detection through imaging BARTON, JENNIFER UNIVERSITY OF ARIZONA AZ $570,435
Ovarian Cancer 2016 NCI 1R44CA206606-01 A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy WILDS, DAN CYNVEC, LLC NY $995,814
Ovarian Cancer 2016 NCI 1R43CA195841-01A1 Isothermal Chain Reaction (ICR) Detection of SNP Biomarkers for Ovarian Cancer Pont-of-Care Testing and Risk Stratification MANCEBO, RICARDO GENENDEAVOR, LLC CA $299,998
Ovarian Cancer 2016 NIGMS 1R35GM119512-01 Connecting BRCA1 functions with DNA crosslink sensitivity LONG, DAVID MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $290,751
Ovarian Cancer 2016 NCI 5R21CA187309-02 Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells BARUA, ANIMESH RUSH UNIVERSITY MEDICAL CENTER IL $171,399
Ovarian Cancer 2016 NCI 5R00CA166228-04 A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer GATZA, MICHAEL RBHS -CANCER INSTITUTE OF NEW JERSEY NJ $249,000
Ovarian Cancer 2016 NCI 5R01CA184717-03 The Regulation of Cisplatin resistance in ovarian cancer ZHU, WENGE GEORGE WASHINGTON UNIVERSITY DC $328,888
Ovarian Cancer 2016 NCI 5K08CA151892-06 Targeting SRC Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer SIMPKINS, FIONA UNIVERSITY OF PENNSYLVANIA PA $130,770
Ovarian Cancer 2016 NCI 5U01CA184910-03 Validation of findings from the Epigenome-Wide Association Study of Breast Cancer STURGEON, SUSAN UNIVERSITY OF MASSACHUSETTS AMHERST MA $181,456
Ovarian Cancer 2016 NCI 5R00CA184415-03 Functional Analysis of LncRNAs in Epithelial Ovarian Cancer LAWRENSON, KATE CEDARS-SINAI MEDICAL CENTER CA $243,541
Ovarian Cancer 2016 NCI 5K22CA181550-02 Targeting defective DNA repair for the prevention of BRCA1-associated cancers ALLI, ELIZABETH WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $162,000
Ovarian Cancer 2016 NIBIB 5R43EB021212-02 CTC Screening Assay to Address Health Disparities in Women with Ovarian Cancer HUPERT, MATEUSZ BIOFLUIDICA, INC NC $199,833
Ovarian Cancer 2016 NCI 2P50CA116201-11 8257 01 Project 1: Cancer risks for mutations in breast cancer predisposition genes COUCH, FERGUS MAYO CLINIC ROCHESTER MN $478,350
Ovarian Cancer 2016 NIGMS 5R01GM116829-02 Structural basis of RNF168-mediated ubiquitin signaling at chromosomal DNA breaks MER, GEORGES MAYO CLINIC ROCHESTER MN $314,025
Ovarian Cancer 2016 NCI 5K22CA181611-02 Online monitoring and image-guided treatment of chemoresistant micrometastases SPRING, BRYAN NORTHEASTERN UNIVERSITY MA $186,396
Ovarian Cancer 2016 NCI 5SC2CA206194-02 Theranostic nanoparticles for dual modality cancer therapy CZAJKOWSKA, ANETA BROOKLYN COLLEGE NY $157,000
Ovarian Cancer 2016 NCI 5P50CA136393-07 7019 Biospecimens and Patient Registry KEENEY, GARY MAYO CLINIC ROCHESTER MN $123,697
Ovarian Cancer 2016 NCI 5P50CA136393-07 7020 Core C - Biostatistics Core OBERG, ANN MAYO CLINIC ROCHESTER MN $150,745
Ovarian Cancer 2016 NCI 5P50CA136393-07 7021 Core D - Animal Models Core HALUSKA, PAUL MAYO CLINIC ROCHESTER MN $138,765
Ovarian Cancer 2016 NCI 5P50CA136393-07 7022 Administrative Core KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $527,228
Ovarian Cancer 2016 NCI 5P50CA136393-07 7023 Project 1 - PARP Project KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $187,355
Ovarian Cancer 2016 NCI 5P50CA136393-07 7024 Project 6 - PKC Iota FIELDS, ALAN MAYO CLINIC ROCHESTER MN $272,554
Ovarian Cancer 2016 NCI 5P50CA136393-07 7025 Project 7 - Metformin LENGYEL, ERNST MAYO CLINIC ROCHESTER MN $338,318
Ovarian Cancer 2016 NCI 5P50CA136393-07 7026 Project 8 - TH17 Dendritic Cell Vaccine KNUTSON, KEITH MAYO CLINIC ROCHESTER MN $280,591
Ovarian Cancer 2016 NCI 5P50CA136393-07 7027 Developmental Reserach Pilot Projects CLIBY, WILLIAM MAYO CLINIC ROCHESTER MN $95,166
Ovarian Cancer 2016 NCI 5P50CA136393-07 7028 Career Development GOODE, ELLEN MAYO CLINIC ROCHESTER MN $47,581
Ovarian Cancer 2016 NCI 5P01CA087969-17 8092 Core A: Biospecimen and High-Dimensional Data Management Core TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $629,635
Ovarian Cancer 2016 NCI 5P01CA087969-17 8096 Project 3: Ovarian Cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $240,294
Ovarian Cancer 2016 NCI 5P01CA087969-17 8097 Project 4: Statistical Innovations ROSNER, BERNARD BRIGHAM AND WOMEN'S HOSPITAL MA $168,164
Ovarian Cancer 2016 NCI 5R01CA142746-07 Enzyme-instructed self-assembly for molecular anticancer nanomedicines XU, BING BRANDEIS UNIVERSITY MA $368,145
Ovarian Cancer 2016 NCI 2P30CA036727-30 5725 Molecular and Biochemical Etiology (MBE) BAND, HAMID UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $57,053
Ovarian Cancer 2016 NCI 1R01CA207034-01 Mechanism of evasion by ovarian cancers from anti-VEGF therapy NAORA, HONAMI UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Ovarian Cancer 2016 NCI 1R01CA207497-01 Provectors for treatment of ovarian cancer SUH, JUNGHAE RICE UNIVERSITY TX $365,548
Ovarian Cancer 2016 NCI 1R01CA207456-01 Epidemiology and biology of lncRNAs in ovarian cancer SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $991,197
Ovarian Cancer 2016 NCI 5P01CA190174-02 7470 Adminstrative Core SPRIGGS, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $81,926
Ovarian Cancer 2016 NCI 5P01CA190174-02 7471 Biostatistics Core IASONOS, ALEXIA SLOAN-KETTERING INST CAN RESEARCH NY $79,911
Ovarian Cancer 2016 NCI 5P01CA190174-02 7472 Pathology Core DELAIR, DEBORAH SLOAN-KETTERING INST CAN RESEARCH NY $81,925
Ovarian Cancer 2016 NCI 5P01CA190174-02 7473 MUC16 Antibody Based Strategies for Imaging and Therapy SPRIGGS, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $573,457
Ovarian Cancer 2016 NCI 5P01CA190174-02 7474 Personalized Immunotherapy of Patients with Ovarian Cancer SABBATINI, PAUL SLOAN-KETTERING INST CAN RESEARCH NY $491,531
Ovarian Cancer 2016 NCI 5P01CA190174-02 7475 Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells BRENTJENS, RENIER SLOAN-KETTERING INST CAN RESEARCH NY $409,610
Ovarian Cancer 2016 NCI 5P01CA190174-02 7476 Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain RAVETCH, JEFFREY SLOAN-KETTERING INST CAN RESEARCH NY $315,472
Ovarian Cancer 2016 RMAP 1R21CA207816-01 Integrated Digital Microfluidic Platforms for Next-Generation Glycomics ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE KS $292,762
Ovarian Cancer 2016 NCI 3U01CA168409-04S1 COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS POWERS, SCOTT COLD SPRING HARBOR LABORATORY NY $70,071
Ovarian Cancer 2016 NCI 1R15CA202775-01A1 Targeting IKK and HDAC Mediated IL-8 Expression in Ovarian and Prostate Cancer VANCUROVA, IVANA ST. JOHN'S UNIVERSITY NY $495,000
Ovarian Cancer 2016 NCI 2R01CA157664-06 Initiation and Evolution of the Ovarian cancer Microenvironment CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $451,250
Ovarian Cancer 2016 NCI 1R21CA208610-01 Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $196,475
Ovarian Cancer 2016 NCI 1R01CA208753-01 Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies ORSULIC, SANDRA CEDARS-SINAI MEDICAL CENTER CA $400,313
Ovarian Cancer 2016 NCI 1R21CA202745-01A1 Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma NELSON, RANDY OHIO STATE UNIVERSITY OH $200,970
Ovarian Cancer 2016 NIGMS 2R01GM059078-17 Molecular Probes for Biomembrane Recognition SMITH, BRADLEY UNIVERSITY OF NOTRE DAME IN $413,571
Ovarian Cancer 2016 NCI 2R01CA155025-06A1 The role of a BRCA1 associated complex in DNA damage response and tumor suppression WANG, BIN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $380,000
Ovarian Cancer 2016 NCI 1R01CA181663-01A1 Mechanisms of radioresistance and strategies for radiosensitization in OCCC PENG, GUANG UNIVERSITY OF TX MD ANDERSON CAN CTR TX $377,816
Ovarian Cancer 2016 NIBIB 1R01EB020605-01A1 Advanced Salpingoscope for Minimally-Invasive Imaging of the Fallopian Tubes BARTON, JENNIFER UNIVERSITY OF ARIZONA AZ $329,928
Ovarian Cancer 2016 NCI 1R43CA203647-01A1 Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays LIM, MARK AMBERGEN, INC MA $225,000
Ovarian Cancer 2016 NCI 1R21CA209281-01 Development of DNA Polymerase θ Inhibitors for Precision Medicine in BRCA Deficient Cancers POMERANTZ, RICHARD TEMPLE UNIV OF THE COMMONWEALTH PA $201,144
Ovarian Cancer 2016 NCI 4R00CA179137-03 Understanding the origin,initiation,and progression of high-grade serous ovarian cancer KIM, JAEYEON INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $248,999
Ovarian Cancer 2016 NCI 1R21CA209848-01 Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes CHUNG, DONGJUN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $195,098
Ovarian Cancer 2016 NCI 1U24CA209999-01 Monitoring tumor subclonal heterogeneity over time and space MARTH, GABOR UNIVERSITY OF UTAH UT $748,920
Ovarian Cancer 2016 NCI 1F30CA203095-01A1 Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer PRIEDIGKEIT, NOLAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $48,576
Ovarian Cancer 2016 NCI 1F32CA200357-01A1 Role of Follicular Fluid Exosomes on Ovarian/Fallopian Carcinogenesis BRACHOVA, PAVLA UNIVERSITY OF KANSAS MEDICAL CENTER KS $58,453
Ovarian Cancer 2016 NCI 1R01CA210370-01 Early detection of ovarian cancer by serum marker and targeted ultrasound imaging BARUA, ANIMESH RUSH UNIVERSITY MEDICAL CENTER IL $369,877
Ovarian Cancer 2016 NCI 1R43CA206607-01A1 JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer CARTER, DARRICK PAI LIFE SCIENCES, INC. WA $199,997
Ovarian Cancer 2016 NIGMS 1R44GM121096-01 Novel enzymatic site-specific antibody drug conjugation technique to produce homogeneous antibody drug conjugate (ADC)s with improved safety, stability and efficacy HU, SEAN DOPHEN BIOMED, INC. CA $149,625
Ovarian Cancer 2016 NCI 261200800001E-96-0-36 Repository Services for epidemiology studies HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $1,886,169
Ovarian Cancer 2016 NCI 261200800001E-96-0-102 Biospecimen Collection Proteomic HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $4,644,786
Ovarian Cancer 2016 NCI 3UM1CA173642-04S1 Women's Health Initiative Cancer Survivor Cohort ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $170,764
Ovarian Cancer 2016 NCATS 1R21TR001731-01 Ketorolac and Related NSAIDs for Targeting Rho-family GTPases in Ovarian Cancer WANDINGER-NESS, ANGELA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $303,000
Ovarian Cancer 2016 NCI 1U24CA210954-01 iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC ZHANG, BING BAYLOR COLLEGE OF MEDICINE TX $1,004,827
Ovarian Cancer 2016 NCI 1U24CA210955-01 PNNL Proteome Characterization Center LIU, TAO BATTELLE PACIFIC NORTHWEST LABORATORIES WA $1,123,778
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer